Periodontal diseases. Periodontal diseases
Conditions
Interventions
Intervention 1: ketoprofen gel ( 2.5% Sanofi Pharmaceutical plant construction in France ) + 3 % doxycycline (Kharzmai Pharmaceutical manufacture in Iran ) which be put into the periodontal pocket usi
Treatment - Drugs
ketoprofen gel ( 2.5% Sanofi Pharmaceutical plant construction in France ) + 3 % doxycycline (Kharzmai Pharmaceutical manufacture in Iran ) which be put into the periodontal pocket using an insulin sy
ketoprofen gel ( 2.5% Sanofi Pharmaceutical plant construction in France), which be inserted into the periodontal pocket using an insulin syringe .
Sponsors
Deputy of Research Council of Dental Branch Islamic Azad University of Tehran
Eligibility
Sex/Gender
All
Age
30 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: adult patients, older than 18 years old, systemically healthy, and having at least 20 teeth. Exclusion criteria: patients with cavitated caries, no periodontal pockets larger than 4 mm, orthodontic appliances or removable prostheses, allergies to cetylpyridinium or CHX, use of antibiotics and anti-inflammatory drugs in the past 3 months that might alter normal gingival health, oral prophylaxis outside of study; use of oral chlorhexidine products or participation in an oral rinse study within 3 months prior to baseline examination, pregnancy or lactation, smoking.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction of pocket depth. Timepoint: 15 Days. Method of measurement: Periodontal probe. | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction of bleeding on probing. Timepoint: 15 Days. Method of measurement: Periodontal probe. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAmirhossein Farahmand
Dental Branch Islamic Azad University of Tehran
Outcome results
None listed